UNSPSC 51351618: Ormeloxifene or centchroman

This classification denotes an antiestrogen with the molecular formula C30H35NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 44AXY5VE90, chemically known as 3,4-trans-2,2-dimethyl-3-phenyl-4-(p-(beta-pyrrolidinoethoxy)phenyl)-7-methoxychroman but generally known as ormeloxifene, which bears US NIH Compound Identifier 35805. European Medicines Agency schedules Ormeloxifene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09462MIG.

UNSPSC 51351618 Ormeloxifene or centchroman is a Commodity code covering a selective estrogen receptor modulator (SERM) pharmaceutical used primarily in contraception and bone health applications. State and local governments procure this product through health departments, public health agencies, and medical facilities for population health programs, family planning services, and clinical inventory. The code applies to the active pharmaceutical ingredient or finished pharmaceutical product itself, distinguishing it from broader contraceptive or pharmaceutical procurement categories.

The source provided contains no recent state or local contract opportunities tagged to this code. Without posted solicitations, the geographic spread, issuing-body mix, and market activity cannot be characterized. This code likely sees limited state and local procurement volume given the specialized nature of the product and the predominance of federal family-planning funding streams (Title X, Medicaid) that route pharmaceutical procurement through existing vendor agreements or state health department formularies rather than open competitive solicitation.